Results 321 to 330 of about 413,694 (387)
Some of the next articles are maybe not open access.
Comparative trial of low-dose, intradermal, recombinant- and plasma-derived hepatitis B vaccines.
Journal of Infectious Diseases, 1990The immunogenicity and reactogenicity of low-dose, recombinant DNA and plasma-derived hepatitis B vaccines were investigated in a prospective, double-blind, randomized, controlled trial. Volunteers (153) received either recombinant vaccine, 10 micrograms
J. Bryan +9 more
semanticscholar +1 more source
Journal of Virological Methods, 1985
As hepatitis B virus does not replicate in tissue culture systems, it was impossible to prepare a vaccine in the conventional way. However, the surface-antigen of the virus is present in abundance in the blood of certain virus carriers. This phenomenon has been used to develop plasma-derived hepatitis B vaccines and these vaccines are now available. In
openaire +6 more sources
As hepatitis B virus does not replicate in tissue culture systems, it was impossible to prepare a vaccine in the conventional way. However, the surface-antigen of the virus is present in abundance in the blood of certain virus carriers. This phenomenon has been used to develop plasma-derived hepatitis B vaccines and these vaccines are now available. In
openaire +6 more sources
Hepatitis B Vaccines in Clinical Practice
, 1992Interestingly, hepatitis b vaccines in clinical practice that you really wait for now is coming. It's significant to wait for the representative and beneficial books to read.
R. Ellis
semanticscholar +1 more source
Vaccine, 2003
The status and likely impact of existing and potential new combined hepatitis B vaccines were broadly considered at the Viral Hepatitis Prevention Board (VHPB) meeting in Malta, October 2001. The currently available and/or licensed combined hepatitis B vaccines in Europe and the prospects for further such vaccines were reviewed.
FitzSimons, D. +3 more
openaire +4 more sources
The status and likely impact of existing and potential new combined hepatitis B vaccines were broadly considered at the Viral Hepatitis Prevention Board (VHPB) meeting in Malta, October 2001. The currently available and/or licensed combined hepatitis B vaccines in Europe and the prospects for further such vaccines were reviewed.
FitzSimons, D. +3 more
openaire +4 more sources
Vaccine, 1983
Abstract Hepatitis B is endemic in many African, Asian and Pacific countries causing much debilitation and death. The disease can lead to chronic cirrhosis and is closely associated with liver cell cancer. There are in the order of 200 million people that carry the virus and constitute a huge reservoir of infection.
openaire +3 more sources
Abstract Hepatitis B is endemic in many African, Asian and Pacific countries causing much debilitation and death. The disease can lead to chronic cirrhosis and is closely associated with liver cell cancer. There are in the order of 200 million people that carry the virus and constitute a huge reservoir of infection.
openaire +3 more sources
A review of hepatitis B vaccination
Expert Opinion on Drug Safety, 2003Hepatitis B is one of the most important infectious causes of acute and chronic liver disease both in the US and worldwide. In order to combat the life-threatening effects of hepatitis B infection, recombinant hepatitis B vaccines have been developed.
Arthur C. Zahalsky +2 more
openaire +3 more sources
Archives of Pediatrics & Adolescent Medicine, 2004
OBJECTIVES To identify parental perceptions regarding vaccine safety and assess their relationship with the immunization status of children. DESIGN, SETTING, AND PARTICIPANTS Case-control study based on a survey of a sample of households participating ...
B. Bardenheier +5 more
semanticscholar +1 more source
OBJECTIVES To identify parental perceptions regarding vaccine safety and assess their relationship with the immunization status of children. DESIGN, SETTING, AND PARTICIPANTS Case-control study based on a survey of a sample of households participating ...
B. Bardenheier +5 more
semanticscholar +1 more source
Combination Hepatitis A-Hepatitis B Vaccine
BioDrugs, 1997The adult formulation of this combination hepatitis A-hepatitis B vaccine contains 720 enzyme-linked immunosorbent assay units (EU) of formalin-inactivated hepatitis A virus strain HM175 and 20mug of recombinant DNA yeast-derived hepatitis B surface antigen adsorbed onto aluminium salts in 1ml for injection.
Julia A. Balfour, Antona J. Wagstaff
openaire +3 more sources
The Pediatric Infectious Disease Journal, 1996
OBJECTIVES To evaluate the relative safety and immunogenicity of the two recombinant hepatitis B vaccines licensed in the United States with doses recommended for routine immunization of low risk infants and a schedule that corresponds with routine ...
D. Greenberg +8 more
semanticscholar +1 more source
OBJECTIVES To evaluate the relative safety and immunogenicity of the two recombinant hepatitis B vaccines licensed in the United States with doses recommended for routine immunization of low risk infants and a schedule that corresponds with routine ...
D. Greenberg +8 more
semanticscholar +1 more source
Hepatitis B vaccines in patients with chronic renal failure before dialysis.
Journal of Infectious Diseases, 1988Hepatitis B remains a significant risk to patients receiving chronic hemodialysis, but no certain method of prevention has been identified. We tested two vaccines, plasma-derived vaccine (40-micrograms dose) and recombinant-derived vaccine (40-micrograms
B. Seaworth +5 more
semanticscholar +1 more source